Archives for the 'feature2' Category
ProChon’s lead product is BioCart, a second-generation tissue regeneration implant for the treatment of joint cartilage defects and injuries.
29 August 2010 |
Blog, Sentinel 2, feature2 |
Although back pain is common, it can be difficult for physicians to determine the exact cause of the pain using current testing methods.
29 August 2010 |
Blog, Sentinel 1, feature2 |
NWL seeks to prevent degeneration and restore function in damaged tissue, particularly in the nervous system.
29 August 2010 |
Blog, Sentinel 2, feature2 |
Novadaq Technologies (TSX: NDQ) develops and markets real-time fluorescence imaging technologies for use in the operating room.
27 August 2010 |
Blog, Sentinel 2, feature2 |
The administration of the device plus the administration of as-needed anti-VEGF therapy is showing promising results.
25 August 2010 |
Blog, Sentinel 1, feature2 |
For many breast cancer patients, the effects of undergoing a mastectomy go well beyond the physical.
23 August 2010 |
Blog, Uncategorized, feature2 |
The Danville, Calif.-based company offers CaseReader, a software solution that is designed to deliver faster, more accurate analysis of image scans.
23 August 2010 |
Blog, Uncategorized, feature2 |
Advances in medicine have allowed people in developed countries to live longer, but at a cost: An increased lifespan raises a patient’s likelihood of developing health issues such as angina or incontinence.
20 August 2010 |
Blog, feature2 |
If your body’s autonomic nervous system (ANS) is working properly, you probably won’t notice it.
19 August 2010 |
Blog, feature2 |
EpiCept’s lead product, Ceplene, is approved for marketing in the EU for the maintenance of first remission in patients with acute myeloid leukemia.
18 August 2010 |
Blog, Member Spotlight, feature2 |
